Demonstration of the open and closed administration techniques for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

被引:0
|
作者
Thompson, Claire [1 ]
Corry, Edward [1 ]
Walsh, Tom [1 ]
Mcvey, Ruaidhri [2 ]
Wilkinson, Michael [1 ]
Khan, Mohammed Faraz [3 ]
Shields, Conor [3 ]
Grehan, Florence [4 ]
Mulsow, Jurgen [3 ]
Brennan, Donal [5 ]
机构
[1] Mater Misericordiae Univ Hosp, Dublin, Ireland
[2] Univ Coll Dublin, Mater Hosp, Ucd Sch Med, Gynaecol Oncol Grp, Dublin, Ireland
[3] Mater Misericordiae Univ Hosp, Peritoneal Malignancy Inst, Dublin, Ireland
[4] Mater Misericordiae Univ Hosp, Biomed Imaging Dept, Dublin, Ireland
[5] Mater Misericordiae Univ Hosp, UCD Sch Med, UCD Gynaecol Oncol Grp, Dublin, Ireland
关键词
D O I
10.1136/ijgc-2024-IGCS.641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SF017/#111
引用
收藏
页码:A363 / A363
页数:1
相关论文
共 50 条
  • [21] Hyperthermic intraperitoneal chemotherapy (HIPEC) is cost-effective in the management of primary ovarian cancer
    Behbakht, Kian
    Cohn, David E.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 4 - 5
  • [22] Ovarian cancer survival outcomes of debulking surgery in the hyperthermic intraperitoneal chemotherapy (HIPEC) era
    Bell, Sarah
    Sukumvanich, Paniti
    Rush, Shannon
    Berger, Jessica
    Edwards, Robert
    Buckanovich, Ronald
    Mahdi, Haider
    Lesnock, Jamie
    Olawaiye, Alexander
    Courtney-Brooks, Madeleine
    Garrett, Alison
    Lin, Jeff
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S327 - S328
  • [23] Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Primary Treatment of Ovarian Cancer: A Review of the Current Literature
    Zirak-Schmidt S.
    Verwaal V.J.
    Indian Journal of Gynecologic Oncology, 2018, 16 (3)
  • [24] Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review
    Ghirardi, Valentina
    Trozzi, Rita
    Giudice, Elena
    Scambia, Giovanni
    Fagotti, Anna
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (02) : 335 - 340
  • [25] Cytoreductive Reductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian Cancer
    Tan, G.
    Chia, C.
    Teo, M.
    Soo, K. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 839 - 839
  • [26] A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer
    Chiva, Luis M.
    Gonzalez-Martin, Antonio
    GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 130 - 135
  • [27] Intraoperative anesthesia considerations with utilization of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer
    Chichura, A. M.
    Chambers, L. J. Moulton
    Costales, A. B.
    Rose, P. G.
    Michener, C. M.
    Mahdi, H.
    Yao, M.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 254 - 255
  • [28] Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer
    Costales, A. B.
    Chambers, L. Moulton
    Chichura, A. M.
    Rose, P. G.
    Mahdi, H.
    Michener, C. M.
    Yao, M.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 259 - 259
  • [29] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian Cancer - An Asian Experience
    Chia, C. S.
    Tan, G.
    Tham, C.
    Soo, K.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S111 - S111
  • [30] CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
    Lim, Myong Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 36 (01)